PDCD1 and cancer: PD-1 and PD-L1 antibodies have been demonstrated to be potent in treating several types of cancers, including cutaneous melanoma, non-small cell lung cancer, renal cell carcinoma, bladder cancer, head and neck cancers, as well as Hodgkin’s lymphoma [18].